Last night bit.bio won the Emerging Star prize at the European Mediscience Awards in a ceremony at the Hotel InterContinental in London. This press release features multimedia. View the full release
Data presented on human muscle, CNS and immune cells and associated disease models Cells have been developed with the company's opti-oxTM precision cellular reprogramming technology
bit.bio announced Monday that it has launched its Huntington’s Disease (HD) cell model to accelerate drug discovery and screening for patients with the disease.